Stock Research for SNSS


Featured Broker: Ally Invest

Get the due diligence for another stock.


SNSS Stock Chart & Research Data

The SNSS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SNSS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


SNSS Due diligence Resources & Stock Charts

The SNSS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SNSS Detailed Price Forecast - CNN Money CNN View SNSS Detailed Summary - Google Finance
Yahoo View SNSS Detailed Summary - Yahoo! Finance Zacks View SNSS Stock Research & Analysis -

Stock Analysis

TradeIdeas View SNSS Trends & Analysis - Trade-Ideas Barrons View SNSS Major Holders - Barrons
NASDAQ View SNSS Call Transcripts - NASDAQ Seeking View SNSS Breaking News & Analysis - Seeking Alpha
Spotlight View SNSS Annual Report - OTC Report View SNSS OTC Short Report -
TradeKing View SNSS Fundamentals - TradeKing Charts View SNSS SEC Filings - Bar Chart
WSJ View Historical Prices for SNSS - The WSJ Morningstar View Performance/Total Return for SNSS - Morningstar
MarketWatch View the Analyst Estimates for SNSS - MarketWatch CNBC View the Earnings History for SNSS - CNBC
StockMarketWatch View the SNSS Earnings - StockMarketWatch MacroAxis View SNSS Buy or Sell Recommendations - MacroAxis
Bullish View the SNSS Bullish Patterns - American Bulls Short Pains View SNSS Short Pain Metrics -

Social Media Mentions

StockTwits View SNSS Stock Mentions - StockTwits PennyStocks View SNSS Stock Mentions - PennyStockTweets
Twitter View SNSS Stock Mentions - Twitter Invest Hub View SNSS Investment Forum News - Investor Hub
Yahoo View SNSS Stock Mentions - Yahoo! Message Board Seeking Alpha View SNSS Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for SNSS - Insider Cow View Insider Transactions for SNSS - Insider Cow
CNBC View SNSS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SNSS - OTC Markets
Yahoo View Insider Transactions for SNSS - Yahoo! Finance NASDAQ View Institutional Holdings for SNSS - NASDAQ

Stock Charts

FinViz View SNSS Stock Insight & Charts - StockCharts View SNSS Investment Charts -
BarChart View SNSS Stock Overview & Charts - BarChart Trading View View SNSS User Generated Charts - Trading View

Latest Financial News for SNSS

Should You Worry About The Sunesis Pharmaceuticals Inc’s (NASDAQ:SNSS) Shareholder Register?
Posted on Wednesday September 12, 2018

A look at the shareholders of Sunesis Pharmaceuticals Inc (NASDAQ:SNSS) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership. Conversely,Read More...

Edited Transcript of SNSS earnings conference call or presentation 7-Aug-18 8:30pm GMT
Posted on Thursday September 06, 2018

Q2 2018 Sunesis Pharmaceuticals Inc Earnings Call

Sunesis Pharmaceuticals to Present at the Wells Fargo Securities 2018 Healthcare Conference
Posted on Thursday August 30, 2018

Sunesis Pharmaceuticals, Inc. (SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President, Finance and Corporate Development of Sunesis, will present at the Wells Fargo Securities 2018 Healthcare Conference on Thursday, September 6, 2018 at 10:20 A.M. Eastern Time at the Westin Copley Place in Boston, MA. Sunesis has built an experienced drug development organization committed to improving the lives of people with cancer. The Company is focused on advancing its novel kinase-inhibitor pipeline, with an emphasis on establishing proof of concept that its oral non-covalent BTK-inhibitor vecabrutinib is effective in ibrutinib-resistant chronic lymphocytic leukemia.

Sunesis: 2Q Earnings Snapshot
Posted on Tuesday August 07, 2018

The South San Francisco, California-based company said it had a loss of 20 cents per share. In the final minutes of trading on Tuesday, the company's shares hit $2.45. A year ago, they were trading at ...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.